Abstract Purpose: To document the utilization of traditional medicines in managing human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) opportunistic infections in sub-
INTRODUCTION
The acquired immunodeficiency syndrome (AIDS), caused by infection with the human immunodeficiency virus (HIV) has become a devastating epidemic in sub-Saharan Africa [1] . Ethnobotanical studies conducted in the following sub-Saharan African countries indicated that traditional healers and local communities extensively use medicinal plants to manage the effects of HIV/AIDS in Cameroon [2] , Namibia [3, 4] , Rwanda [5] , South Africa [6] [7] [8] , Sudan [9] , Tanzania [1, 10] and Uganda [11] [12] [13] .
Despite the increasing acceptance of traditional medicines as an additional and alternative therapeutic strategy in the fight against HIV/AIDS opportunistic diseases in sub-Saharan Africa [1] [2] [3] [4] 7, 8, [10] [11] [12] [13] , this rich indigenous knowledge on traditional remedies is not adequately documented. Documentation of plants used for treating and managing HIV/AIDS opportunistic diseases in sub-Saharan Africa is urgent as there is need to search for novel anti-HIV compounds. Moreover, an estimated 25 % of pharmaceutical drugs and 11 % of drugs considered essential by WHO are derived from plants; a large number of synthetic drugs obtained from precursor compounds originating from plants [14] .
Medicinal plants used for treating and managing HIV/AIDS opportunistic diseases in sub-Saharan Africa are an integral part of a culturally accepted and holistic health care system that has been in existence for several generations. Therefore, traditional medicines are possible sources of complementary and alternative medicines for HIV/AIDS opportunistic diseases.
This review briefly examines the role of herbal medicines in the fight against HIV/AIDS opportunistic diseases in sub-Saharan Africa. It is hoped that this review will provide important and relevant information that will form a basis for further research to identify and isolate bioactive constituents that can be developed as drugs for the treatment and management of HIV/AIDS opportunistic diseases.
EXPERIMENTAL
In this study, the focus was on herbal plants that are used to treat or manage HIV/AIDS opportunistic diseases in sub-Saharan Africa, and also reported to have anti-viral bioactivity based on in vitro or in vivo studies. Only papers that included information on plant identity, the HIV/AIDS opportunistic diseases treated and plant part(s) used were included in this review.
The
International Plant Name Index (www.ipni.org) and the Royal Botanic Garden and Missouri Botanic Garden plant name database (www.theplantlist.org) were used to validate plant scientific names, plant families and plant authorities. In addition to this, the anti-viral efficacy of the documented plant species, either in vitro or in vivo was also verified from published literature. Therefore, this review draws heavily on the results of ethnobotanical surveys undertaken in contemporary sub-Saharan Africa on traditional medicines used to treat or manage HIV/AIDS opportunistic diseases [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] , as well as secondary data collected through a review of 60 research reports, policy documents, reports from national, regional and international organizations, and conference papers published in scientific journals (53), books (4), theses (2) and one as an abstract.
Literature was searched on international online databases such as ISI Web of Science, MEDLINE, Science Direct, Scopus and Google Scholar using specific search terms such as "herbal medicines used to treat HIV/AIDS opportunistic diseases", "medicinal plants used to treat HIV/AIDS opportunistic diseases", "traditional medicines used to treat HIV/AIDS opportunistic diseases", and "anti-viral activity of [each documented plant species]". References were also identified by searching the library collections of the National Herbarium and Botanic Gardens, Zimbabwe and University of Fort Hare, South Africa.
FINDINGS
This study recorded 74 plant species widely used traditionally in treating and managing HIV/AIDS opportunistic diseases in sub-Saharan Africa (Table 1 . These medicinal plants were distributed among 37 families and 65 genera. The majority of medicinal plants (50, 67.6 %) used to treat and manage HIV/AIDS opportunistic diseases in subSaharan Africa were from 13 families ( Table 2) . Plant families with the highest number of medicinal plants were Fabaceae sensu lato (11 species), followed by Asteraceae and Euphorbiaceae (5 species each), Combretaceae, Lamiaceae and Myrtaceae (4 species each), Amaryllidaceae, Cucurbitaceae and Phyllanthaceae (3 species each), Apiaceae, Celastraceae, Clusiaceae and Xanthorrhoeaceae (2 species each). The rest of the families were represented by one species each ( Table 1 ). The genera with highest number of species were Combretum with three species, followed by Artemisia, Cucurbita, Euphorbia, Garcinia, Plectranthus, Senna and Syzygium with 2 species each ( Table 1) .
Growth form and plant parts used
Trees (43.2 %) were the primary sources of the medicinal plants used for treating and managing HIV/AIDS opportunistic diseases in sub-Saharan Africa, followed by shrubs (27 %), herbs (24.3 %) and climbers (5.4 %) ( Table 1 ). The plant parts used for making herbal preparations were the bark, bulbs, fruits, leaves, leaf sap, roots, stem, tubers and twigs ( Table 1 ). The leaves (67.6 %) were the most frequently used, followed by roots (35.1 %), bark (31.1 %), bulb and seeds (5,4 % each), fruits, stem and twigs (2.7 % each), tubers and leaf sap (1.4 % each) ( Table 1) . Anti-HIV activity [22] Artemisia annua L.
Shrub Leaves Bacterial/fungal infections (Uganda) [11] , skin infections (Cameroon) [2] Anti-HIV activity [22] Aspilia pluriseta Schweinf.
Herb Leaves Kwashiorkor, worms, wounds (Rwanda) [5] Anti-HIV activity [5] Tithonia diversifolia (Hemsl.) A. Gray Shrub Leaves Ascariasis, diarrhea (Rwanda) [5] Anti-HIV activity [5] Vernonia amygdalina Del.
Shrub Leaves/roo ts
Ascariasis, hepatitis, malaria (Rwanda) [5] , diarrhea, herpes zoster (Tanzania, Uganda) [1, 10, 11] , cryptococcal meningitis, herpes simplex (Cameroon, Tanzania) [1, 2, 10] , skin infections (Cameroon) [2] , boost appetite/immunity, stomach ache, fever (Cameroon, Uganda) [2, 11, 13] , skin rash (Cameroon, Tanzania, Uganda) [1,2,10,13], backache, cough, headache (Cameroon, Uganda) [2, 13] , stomachache (Uganda) [13] Anti-HIV activity [23] Bignonaceae Kigelia africana (Lam.) Benth.
Tree Bark/fruits Herpes simplex (Namibia, Tanzania) [1, 3, 4] , diarrhea (Namibia) [3] , skin rash (Uganda) [12] Inhibits HIV-1 reverse transcriptase [24] Brassicaceae Raphanus sativus L. 
Herb
Leaves Cough, diarrhea, fever, skin rash (Uganda) [13] Anti-HIV activity [32] Euphorbiaceae Croton lechleri Müll. Arg.
Tree Bark Anaemia, boost appetite, diarrhea (Namibia) [3] Antiviral activity [33] Euphorbia hirta L. Herb Leaves/r oots Bacterial/fungal infections, herpes zoster (Uganda) [11] , dermatophytoses (South Africa) [8] Inhibits HIV-1, 2 reverse transcriptase [34] Euphorbia tirucalli L.
Shrub
Leaves Cough, tuberculosis (Uganda) [11] Anti-HIV activity [35] Jatropha curcas L. Shrub Leaves Herpes zoster (Uganda) [11] , oral candidiasis, skin rash (Tanzania) [1, 10] Anti-HIV activity [36] Ricinus communis L.
Shrub Roots Abortifacient, abscesses, antihelmentic, arthritis, asthma, dermatitis, diarrhea, fever, flu, toothache, tuberculosis, wounds (South Africa) [6] , cough (Tanzania) [1, 10] Inhibits HIV-1 reverse transcriptase [6] Fabaceae Bulbine alooides (L.) Willd.
Herb Leaves/r oots
Burns, cracked lips, diarrhea, herpes simplex, itching, skin rash, ringworm, vomiting, wounds (South Africa) [16, 17] Anti-HIV activity [16] Zingiberaceae Zingiber officinalis L.
Herb Bulb Aspergillosis (South Africa) [8] , boost appetite/immunity, cough, tuberculosis (Uganda) [11] , skin infections (Cameroon) [2] Anti-HIV-1 activity [60] (Table 3) .
DISCUSSION
The checklist in Table 1 provides baseline data on medicinal plants that are currently used to treat and manage HIV/AIDS opportunistic diseases in sub-Saharan Africa. This inventory is a crucial starting point in trying to assess the efficacy of traditional medicines in the management of HIV/AIDS opportunistic diseases as well as the development of effective drugs for the treatment of HIV/AIDS. One of the possible approaches to finding novel anti-HIV therapeutic agents is the screening of medicinal plants that are widely used in local communities to treat and manage HIV/AIDS opportunistic diseases.
Out of 74 medicinal plants widely used in subSaharan Africa to treat and manage HIV/AIDS opportunistic diseases, 63 species (85.1 %) have proven anti-HIV active compounds and known modes of action (Table 1) . Among these is Kigelia africana used to treat diarrhea and herpes simplex in Namibia [3] , herpes simplex in Tanzania [1] and skin rash in Uganda [12] . Maytenus senegalensis is used as herbal medicine for bacterial/fungal infections and cough in Uganda [11] , and to treat herpes simplex/zoster, oral candidiasis, skin rash and tuberculosis in both Tanzania and Uganda [1, [10] [11] [12] . Similarly, Garcinia buchananii has the same ethnomedicinal applications in Namibia [3] and Tanzania [1] as herbal medicine for chronic diarrhea, cryptococcal meningitis, herpes simplex/zoster, skin rash and tuberculosis [1, 3, 10] .
Another noteworthy plant species used for treating and managing HIV/AIDS opportunistic diseases in sub-Saharan Africa are Hypoxis hemerocallidea and Sutherlandia frutescens (Table 1) . These two species are currently recommended by the South African Ministry of Health for HIV management [6, 17, 42] . This is in accordance with the World Health Organization's recommendation that traditional medicines should be included in national responses to HIV/AIDS pandemic [14] . Some of these species can, therefore, be targeted for phytochemical and pharmacological studies with the aim of identifying active ingredients contained by such plants required for treating and managing HIV/AIDS. Such research is important, as there is need to search for improved antiretroviral agents which can be added to or replace the current drugs in use.
Despite the presence of anti-HIV activity in more than 85 % of the plant species in Table 1 This study revealed that many people in subSaharan Africa use traditional medicines for the treatment and management of HIV/AIDS opportunistic diseases despite the increasing availability of antiretroviral therapy. People in sub-Saharan Africa, particularly the poor are still dependent on medicinal plants for the treatment of basic human ailments like backache, cold, cough, diarrhea, fever, headache, skin infections and wounds [14, 17, 24, 44] . Therefore, traditional medicines remain the main source of primary health care available and accessible to all people in sub-Saharan Africa.
Although no plant-derived drug is currently in clinical use to treat and manage HIV/AIDS opportunistic diseases, knowledge on these plants is very important as this can serve as leads in the discovery of new anti-HIV agents. Medicinal plants may yield novel compounds that may be of interest for HIV/AIDS drug development particularly those medicinal plants characterized by anti-HIV activity ( Table 1) .
Limitations of the study
This study has taken a focused approach and generated extensive exploratory and qualitative data, however, the following limitations are acknowledged in relation to its findings. Detailed accounts of plants used to treat and manage HIV/AIDS opportunistic diseases are available from Cameroon, Namibia, Rwanda, South Africa, Sudan, Tanzania and Uganda only. Although, the results from these countries are diverse in nature, they may not apply directly to all countries in the sub-Saharan Africa. The advantages of this limited sample size and sharp focus on detailed accounts on medicinal plants used to treat and manage HIV/AIDS opportunistic diseases in Cameroon, Namibia, Rwanda, South Africa, Sudan, Tanzania and Uganda resulted in a better and deeper understanding of traditional medicines useful for HIV/AIDS management in sub-Saharan Africa. Overall, while the study is useful in gaining an understanding of utilization of traditional medicines in managing HIV/AIDS opportunistic infections in sub-Saharan Africa and the value of traditional medicines in a wide spectrum of countries in the region, it is clear that more detailed national level studies should be undertaken. The present study provided a sample of preliminary data that could open up pertinent questions relating to the management of HIV/AIDS opportunistic infections using herbal medicines.
CONCLUSION
Correlation between the ethnomedicinal employment and the pharmacological activities have been duly observed and described in this study. In fact, this study suggests that some of the plant species have the potential to be developed as anti-HIV agents. While there are still gaps in the phytochemistry and pharmacological studies conducted so far, which need to be bridged in order to exploit the full medicinal potential of these species, it is still very clear that these plant species have tremendous potential for the future. This inventory will assist future workers on the selection of herbal plants to evaluate for phytochemical safety and pharmaceutical efficacy. There is also need for more research on the active compounds of these herbal medicines, some of which have already shown interesting pharmacological activities as shown in Table 1 .
